27 December 2018 - 2018 has been a historic year in the fight to end TB. Never before have we had a political declaration for TB endorsed by Heads of State to accelerate the TB response and a UN High Level Meeting on TB. This has been the culmination of intensive joint work and collaboration, that began with the WHO Global Ministerial Conference on Ending TB in Moscow in November 2017, followed by several regional events, the Interactive Civil Society Hearing in June and other key events.
21 December 2018 – “The new WHO recommendations, based on the most recent available evidence, signal an important departure from previous approaches to treat MDR/RR-TB. Injectable agents are no longer among the priority medicines when designing longer MDR-TB regimens and fully oral regimens should thus become the preferred option for most patients”, stated Dr Tereza Kasaeva, Director of WHO’s Global TB Programme.
17 December 2018 - TDR and the Global Tuberculosis Programme of the World Health Organization (WHO) are supporting countries in West and Central Africa to investigate the costs faced by patients and households affected by tuberculosis (TB).
Patients with TB often incur large costs related to illness and disability. These include medical and non-medical costs associated with seeking and receiving health care, and costs related to loss of income. Such costs can create access barriers to TB services and increase the risk of disease transmission. They also place an economic burden on households, which can push people below the poverty line or deeper into poverty.
12 December 2018 - The World Health Organization (WHO) has revamped its Civil Society Task Force on TB (CSTF) to strengthen collaboration for accelerating progress towards ending TB. The revamped task force is a culmination of the commitments made by WHO’s Director-General Dr Tedros Adhanom Ghebreyesus to strengthen civil society engagement, as discussed at several consultations with civil society representatives, starting from the Ministerial Conference on Ending TB which took place in Moscow in November 2017.
30 November 2018 - This year marks a special milestone for the fight to end AIDS, as the world comes together to commemorate the 30th anniversary of the first World AIDS Day - that was initiated by WHO in 1988. The global theme this year is “Know your status”, I would like to add a simple mantra to this - “and be free from TB”. TB is the leading killer of people with HIV, and 920 000 people living with HIV fell ill with TB in 2017. Despite the progress in antiretroviral treatment coverage, nearly half of those who fall ill with HIV-associated TB and lose their lives from it, do not even reach the services they urgently need
16 November 2018 - In less than a year, the fight to end TB has been in the spotlight twice with two high level meetings: the first WHO Global Ministerial Conference on Ending TB in the Sustainable Development Era: A Multisectoral Response held in Moscow in November 2017 and the first-ever United Nations High Level Meeting on the fight to end TB held in New York in September 2018.
WHO strongly supports global sharing of data from TB clinical trials to maximize learning and accelerate discoveries
06 November 2018 - To advance the development of new treatments against all forms of TB and maximize the impact of studies and trials undertaken in this area, WHO and partners have initiated a series of pioneering initiatives over the past few years. These are now bearing fruit.
02 November 2018 - The 49th Union World Conference on Lung Health, held from 24-27 October in The Hague brought together an unprecedented number of stakeholders from the TB community and beyond. The World Health Organization (WHO) organized several meetings and consultations on the side-lines of the conference. Below is a brief roundup of key WHO-led events.
54 millionlives were saved through effective diagnosis and treatment, 2000-2017.Fact sheet on tuberculosis
558 000people resistance to rifampicin (the most effective first-line drug) globally in 2017, of which 82% had Multidrug-resistant Tuberculosis (MDR-TB).Q&A on MDR-TB
3.5 billionUS dollars per year needed to fill resource gap for implementing existing TB interventions.Global TB report facts
UNGA high-level meeting on TB
The United Nations General Assembly first-ever high-level meeting on tuberculosis (TB) aims to accelerate efforts in ending TB and reach all affected people with prevention and care. It will be convened by the President of the General Assembly in New York on 26 September 2018 under the theme “United to end tuberculosis: an urgent global response to a global epidemic”.
Our work & priorities
- Detection and diagnosis
- Treatment and care
- Preventive care
- Drug-resistant TB
- TB and HIV
- Child and Adolescent TB
- Addressing needs of vulnerable populations
- Technical support to countries
- Community engagement: ENGAGE-TB
- Public-Private Mix
- Monitoring and evaluation
- Digital health
- Zoonotic TB
Who we are
WHO's End TB Strategy
Resources & publications
TB fact sheets
- TB fact sheet
End TB Strategy fact sheet
- More fact sheets on TB by topic
- 10 facts on tuberculosis
- What is TB? How is it treated?
- What is multidrug-resistant tuberculosis (MDR-TB) and how do we control it?
WHO guidelines on TB
Global TB Programme - 2018: Year in Review. Looking back to move forward into 2019
WHO updates its treatment guidelines for multidrug- and rifampicin-resistant tuberculosis
Feature stories on TB
Global Ministerial Conference
WHO Director-General Dr Tedros video statement for World TB Day 2018
World TB day
World TB Day is an opportunity to raise awareness about the burden of tuberculosis (TB) worldwide and the status of TB prevention and control efforts.
Activities of the Strategic and Technical Advisory Group for TB (STAG-TB), Task Force on TB Impact Measurement, Latent TB Infection Task Force, HIV/TB Task Force and the Task Force for New Drug Policy Development.
Ending TB in the WHO regions
The WHO Global TB Programme is responsible for coordinating WHO's global efforts to end TB. You can contact us at: email@example.com